Clinical trial

Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL)

NCT01029925

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2009-12-01

PhasePHASE2

Study timeline

Study start (unknown)2009-12-01Date precision: month

Registry last updated2016-02-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Breast Cancerunresolved

Lung Cancerunresolved

Interventions

Dichloroacetate (DCA)DRUG

Sponsors & collaborators

Jonsson Comprehensive Cancer Centerlead sponsor

Mapped research locations

Los AngelesCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01029925 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.